PainChek Limited (ASX: PCK) Webcast Replay
PainChek (ASX: PCK) is an Australian based company that develops pain assessment technologies. Its smartphone based medical device uses artificial intelligence to assess and score pain levels in real time and update medical records in the cloud.
As a part of our ‘The Insiders’ series, CEO Philip Daffas provides valuable insights to the company, its key markets and industry, and future prospects.
Recorded on 16 December 2020 at 12pm (AEDT).
Join the next The Insider webcast
FEATURE SPEAKERS
Philip Daffas
Chief Executive Officer - PainChek Limited (ASX: PCK)
PainChek (ASX: PCK) is an Australian based company that develops pain assessment technologies. Its smartphone based medical device uses artificial intelligence to assess and score pain levels in real time and update medical records in the cloud. PainChek records a short video of the person’s face and analyses the images that indicate pain and records them. The caregiver then uses PainChek to observe and record pain, and calculate an overall pain score and stores the result. This allows the caregiver to monitor the effect of medication and treatment over time.
PainChek is being rolled out globally in two phases: first PainChek for adults who are unable to effectively verbalise their pain, such as people with dementia; second PainChek for children who have not yet learnt to speak.
